Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
5
×
life sciences
national blog main
national top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
clinical trials
gene therapy
novartis
vc
cancer
celgene
democrats
immunomedics
ipo
medicare
migraine
What
bio
5
×
ipo
5
×
roundup
new
biogen
medicines
million
week
activity
allogene
america
analysis
approvals
arena’s
biotech
bounty
bring
cancer
cig
clamped
comeback
companies
company
continues
convoluted
corner
covid
crispr
deals
delays
delivered
democrats
develop
developing
diseases
diversity
dreams
drug
economic
employing
Language
unset
Current search:
bio
×
ipo
×
" boston top stories "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More